New Season and Our Resilience to Tackle COVID

Below is my monthly message for the October 2021 edition of the MHRI newsletter, Focus. You can view Focus online at MedStarResearch.org/FOCUS.



Dear Friends and Colleagues,

Welcome to October 2021 filled with a week of beautiful, crisp fall weather but also filled with ongoing pandemic concerns.  What seems to be compounding the situation is the lack of reliable information around so many aspects of this disease. It would be nice to have clear answers to some of our most critical questions such as:

  1. Does mask wearing really make a difference if I am already vaccinated?
  2. When do I develop antibodies from the vaccine and how long do they last?
  3. If I get COVID, how do I know if I am going to get very sick or at high risk to die?
  4. If I go to an emergency room with COVID, how do I know if it is safe to go home?
  5. Once I recovered from COVID, how long do I have antibodies against further disease?
  6. How long will COVID symptoms persist after the infection is over?
  7. Why can’t someone come up with a simple pill to treat this disease?
I want you to know that these, and many other critically important COVID questions, are being worked on and answered by MedStar Health investigators right now!  For example, a late breaking clinical trial conducted in over 800 COVID-19 patients, from 13 medical centers across 9 countries (and led by Dr. Federico Asch at MedStar Washington Hospital Center) found that cardiovascular death from COVID-19 could be predicted from the cardiac ultrasound if (and only if) the interpretation was aided by artificial intelligence but could not be interpreted by the human eye only!  And this is just one of several remarkable studies we are conducing here at MedStar Health.  Just look at the studies in this issue of FOCUS:


Results from MedStar Health’s Centers for Disease Control and Prevention (CDC) Community Research Partnership (CRP) Study of COVID-19 – This population health study, led by Drs Weintraub and Miller, enrolled over 10,000 MedStar Health patients and is answering many of the above questions about how our behaviors (mask wearing, social distancing, etc) and vaccination uptake are having dramatic effects in our community.  Be on the lookout for an upcoming New England Journal of Medicine publication (and over 20 other scientific publications) coming out from this study in the next few months!

MedStar Health Receives FDA Clearance to Trial an Oral Immunomodulatory Drug for COVID-19  -  Drs. Fishbein, Khan, Kroemer and others from MedStar Georgetown Transplant Institute last week received FDA clearance to conduct an investigator initiated clinical trial on a novel oral medication to treat COVID-19.

MedStar Health Investigators Evaluate Trends For Substance Use during the COVID-19 Pandemic -  This multi-disciplinary research team examined over 100,000 substance use screens from across 7 MedStar Health emergency departments and recently published their results  ‘Impact of COVID-19 pandemic on emergency department substance use screens and overdose presentations’ in The American Journal of Emergency Medicine.

A New AHRQ R21 Award will Study When is it Safe to Discharge a COVID-19 Patient from the Emergency Department -  In her first federally funded award, Dr. Galarraga (an emergency medicine physician and health care delivery researcher) will develop an electronic health record screening tool that uses artificial Intelligence/machine learning to predict the risk of Emergency Department return among COVID-19 patients.

The pandemic may be relentless but so are our MedStar Health investigators!  As of a recent review, we have over 250 COVID-related research projects at MedStar Health across a diverse set of clinical disciplines.  We are advancing health across our community at the time of greatest need.  Thank you to all the research teams working on COVID-19 (and the other very important areas of healthcare!) and thank you to all those who support the research teams to make this important work possible.

Enjoy this month’s issue of FOCUS and stay well.

Neil

Read Focus online at MedStarResearch.org/FOCUS.

Comments

Popular posts from this blog

"Betsey, Lucy, and Anarcha: Recognition and Remembrance" with MHRI

World Medical Innovation Forum 2018

MedStar Health's Upcoming Advertising Campaign!